Autonomix Medical (AMIX) investor relations material

Executive summary

• Annual Meeting scheduled for October 29, 2026, with in-person attendance encouraged and electronic proxy voting available.

• Shareholders of record as of September 8, 2026, are eligible to vote on key proposals.

• Proxy materials, including the Annual Report and amendments, are accessible online to reduce environmental impact and costs.

Voting matters and shareholder proposals

• Election of five directors to serve until the 2027 annual meeting.

• Ratification of Forvis Mazars, LLP as independent auditor for fiscal year ending March 31, 2027.

• Approval of an amendment authorizing the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25 within one year.

• Approval of an amendment to the 2023 Equity Incentive Plan to increase authorized shares for issuance.

Board of directors and corporate governance

• Board consists of five members, with a majority deemed independent under Nasdaq rules.

• Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, each with independent members.

• Board and committees held a total of 13 meetings in fiscal 2026, with high attendance.

• Policies in place include anti-hedging, code of ethics, and insider trading policy.